Cargando…

First Demonstration of Cardiac Resynchronization Therapy Defibrillator Service Life Exceeding Patient Survival in a Heart Failure with Reduced Ejection Fraction Cohort

The occurrence of patient longevity exceeding implantable cardioverter-defibrillator (ICD) service life has important implications for patient outcomes and the cost of care. Battery capacity as measured in ampere-hours (Ah) is a strong predictor of survival to an elective replacement indicator (ERI)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Jeffrey L., Harley, Bertha, Williams, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MediaSphere Medical 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769506/ https://www.ncbi.nlm.nih.gov/pubmed/33408952 http://dx.doi.org/10.19102/icrm.2020.111203

Ejemplares similares

Evaluation of potential underuse of cardiac resynchronization therapy for heart failure with reduced ejection fraction
por: Takano, Makoto, et al.
Publicado: (2021)

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
por: Schrage, Benedikt, et al.
Publicado: (2021)

Sex‐Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Predictors for early mortality in patients with implantable cardiac defibrillator for heart failure with reduced ejection fraction
por: Çinier, Göksel, et al.
Publicado: (2022)

Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia
por: Kim, Hak Ju, et al.
Publicado: (2016)

Heart failure with recovered ejection fraction and the utility of defibrillator therapy: a review
por: Devgun, Jasneet K., et al.
Publicado: (2021)

Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
por: Tawfik Ghanem, Mazen, et al.
Publicado: (2019)

Prognostic effects of longitudinal changes in left ventricular ejection fraction with cardiac resynchronization therapy
por: Zhang, Nixiao, et al.
Publicado: (2020)

Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project
por: Hadwiger, Moritz, et al.
Publicado: (2022)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure
por: Christie, Simon, et al.
Publicado: (2018)

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
por: Rørth, Rasmus, et al.
Publicado: (2019)

Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure—Role of the Goldenberg risk score
por: Merkel, Eperke D., et al.
Publicado: (2023)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010)

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
por: Gadler, Fredrik, et al.
Publicado: (2016)

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
por: Masarone, Daniele, et al.
Publicado: (2019)

Efficacy of Implantable Cardioconverter Defibrillator or Cardiac Resynchronization Therapy Compared With Combined Therapy in Survival of Patients With Heart Failure: A Meta-Analysis
por: Deng, Jin-Long, et al.
Publicado: (2015)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

What is the Lowest Value of Left Ventricular Baseline Ejection Fraction that Predicts Response to Cardiac Resynchronization Therapy?
por: Agir, Aysen Agacdiken, et al.
Publicado: (2014)

Contrast‐induced nephropathy after cardiac resynchronization therapy implant impairs the recovery of ejection fraction in responders
por: Strisciuglio, Teresa, et al.
Publicado: (2019)

Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life
por: Vu, Katja, et al.
Publicado: (2021)

One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
por: Ishii, Natsuko, et al.
Publicado: (2021)

A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure
por: Tomini, F., et al.
Publicado: (2016)

Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
por: Arai, Shuhei, et al.
Publicado: (2020)

Ventricular arrhythmia events in heart failure patients with cardiac resynchronization therapy with or without a defibrillator for primary prevention
por: Nakamura, Toshihiro, et al.
Publicado: (2022)

Publisher Correction to: Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
Publicado: (2020)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Does defibrillation threshold increase as left ventricular ejection fraction decreases?
por: Val-Mejias, Jesus E., et al.
Publicado: (2010)

Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator
por: Chen, Jie, et al.
Publicado: (2021)

Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review
por: Teimourizad, Abedin, et al.
Publicado: (2021)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
por: Gosling, Rebecca C, et al.
Publicado: (2022)

Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)
por: Hasin, Tal, et al.
Publicado: (2021)

Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator
por: Alasti, Mohammad, et al.
Publicado: (2017)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Implantation of a cardiac resynchronization therapy and defibrillation system using a robotic approach
por: Amraoui, Sana, et al.
Publicado: (2015)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
por: Liu, Fuwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_thm0jkdef4i52g16k5epl9t41o